Petrovsky N - Search Results

1

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.

Gordon DL, Sajkov D, Honda-Okubo Y, Wilks SH, Aban M, Barr IG, Petrovsky N. Gordon DL, et al. Among authors: petrovsky n. Vaccine. 2016 Jul 19;34(33):3780-6. doi: 10.1016/j.vaccine.2016.05.071. Epub 2016 Jun 21. Vaccine. 2016. PMID: 27342914 Free PMC article. Clinical Trial.

2

Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.

Petrovsky N. Petrovsky N. Vaccine. 2006 Apr 12;24 Suppl 2(Suppl 2):S2-26-9. doi: 10.1016/j.vaccine.2005.01.107. Vaccine. 2006. PMID: 16823913 Free PMC article. Review.

3

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.

Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N. Lobigs M, et al. Among authors: petrovsky n. J Gen Virol. 2010 Jun;91(Pt 6):1407-17. doi: 10.1099/vir.0.019190-0. Epub 2010 Feb 3. J Gen Virol. 2010. PMID: 20130134 Free PMC article.

4

Management of dyspnea in advanced pulmonary arterial hypertension.

Sajkov D, Petrovsky N, Palange P. Sajkov D, et al. Among authors: petrovsky n. Curr Opin Support Palliat Care. 2010 Jun;4(2):76-84. doi: 10.1097/SPC.0b013e328338c1e0. Curr Opin Support Palliat Care. 2010. PMID: 20407377 Review.

5

The vaccine renaissance.

Petrovsky N. Petrovsky N. Hum Vaccin. 2011 Feb;7(2):149-52. doi: 10.4161/hv.7.2.14321. Epub 2011 Feb 1. Hum Vaccin. 2011. PMID: 21321480 Free PMC article. No abstract available.

6

Serological responses following influenza A H1N1 2009 infection in adults.

Tan S, Gordon DL, Honda-Okubo Y, Petrovsky N, Phillips P, Huddleston S, Sadlon TA. Tan S, et al. Among authors: petrovsky n. J Infect. 2011 May;62(5):388-93. doi: 10.1016/j.jinf.2011.03.002. Epub 2011 Mar 21. J Infect. 2011. PMID: 21420426

7

Pediatric influenza immunization.

Petrovsky N, Sajkov D. Petrovsky N, et al. Expert Rev Vaccines. 2011 May;10(5):567-70. doi: 10.1586/erv.11.53. Expert Rev Vaccines. 2011. PMID: 21604977 No abstract available.

8

Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.

Layton RC, Petrovsky N, Gigliotti AP, Pollock Z, Knight J, Donart N, Pyles J, Harrod KS, Gao P, Koster F. Layton RC, et al. Among authors: petrovsky n. Vaccine. 2011 Aug 26;29(37):6242-51. doi: 10.1016/j.vaccine.2011.06.078. Epub 2011 Jul 6. Vaccine. 2011. PMID: 21736913 Free PMC article.

9

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.

Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, Cox MM, Heinzel S, Petrovsky N. Gordon DL, et al. Among authors: petrovsky n. Vaccine. 2012 Aug 3;30(36):5407-16. doi: 10.1016/j.vaccine.2012.06.009. Epub 2012 Jun 17. Vaccine. 2012. PMID: 22717330 Free PMC article. Clinical Trial.

10

Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.

Honda-Okubo Y, Saade F, Petrovsky N. Honda-Okubo Y, et al. Among authors: petrovsky n. Vaccine. 2012 Aug 3;30(36):5373-81. doi: 10.1016/j.vaccine.2012.06.021. Epub 2012 Jun 20. Vaccine. 2012. PMID: 22728225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page